发明名称 |
PEGYLATED ALPHA INTERFERON FOR HIV THERAPY |
摘要 |
The uses of pegylated interferon-alfa, alone, and in association with an anti-HIV-1 drug therapy, and ribavirin for the preparation of a medicament for treating treatment-naive as well as treatment-experienced adult and pediatric patients having HIV-1 infections as well as patients co-infected with HIV-1 and HCV involving comprising a therapeutically effective amount of pegylated interferon-alfa, e.g., pegylated interferon alfa-2b as monotherapy or preferably in association with a therapeutically effective amount of at least one of ribavirin, IL-2, IL-12, pentafuside alone or in combination with a therapeutically effective amount of an anti-HIV-1 drug therapy, e.g., HAART are disclosed.
|
申请公布号 |
WO0051631(A3) |
申请公布日期 |
2001.01.18 |
申请号 |
WO2000US05361 |
申请日期 |
2000.03.01 |
申请人 |
SCHERING CORPORATION;LAUGHLIN, MARK, A.;GLUE, PAUL, W.;STALGIS, CARLOS, O. |
发明人 |
LAUGHLIN, MARK, A.;GLUE, PAUL, W.;STALGIS, CARLOS, O. |
分类号 |
A61K38/00;A61K38/21;A61P1/16;A61P31/12;A61P31/18;C07K14/555;(IPC1-7):A61K38/21 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|